Skip to main content
. 2011 Dec 19;30(5):488–496. doi: 10.1200/JCO.2011.34.7898

Table 3.

All Adverse Events Observed in ≥ 10% of Patients

Adverse Event No. % Grade
1 2 3 4
GI
    Diarrhea 22 76 15 7 0 0
    Nausea 17 59 11 6 0 0
    Vomiting 9 31 8 0 1 0
    Decreased appetite 6 21 5 1 0 0
    Dyspepsia 4 14 3 1 0 0
    Abdominal pain 4 14 4 0 0 0
General
    Fatigue 10 35 4 5 0 1
    Peripheral edema 6 21 4 2 0 0
    Insomnia 5 17 2 3 0 0
    Pyrexia 4 14 2 2 0 0
    Dizziness 4 14 2 2 0 0
    Headache 4 14 4 0 0 0
    Hypertension 3 10 1 2 0 0
Blood
    Thrombocytopenia 8 28 0 0 3 5
    Neutropenia 8 28 0 0 1 7
    Epistaxis 5 17 4 1 0 0
    Contusion 4 14 3 1 0 0
Respiratory
    Cough 9 31 6 3 0 0
    Upper RTI 7 24 2 5 0 0
    Sinusitis 6 21 2 4 0 0
    Lower RTI 4 14 0 1 3 0
    Pneumonia 4 14 0 1 2 1
    Productive cough 4 14 4 0 0 0
    Nasopharyngitis 4 14 4 0 0 0
    Dyspnea 3 13 2 1 0 0
Pain
    Arthralgia 4 14 2 2 0 0
    Oropharyngeal 3 10 2 1 0 0
    Extremity 3 10 0 3 0 0
Skin
    Basal cell carcinoma 4 14 0 3 1 0
    Skin lesion 4 14 1 2 1 0
    Dry skin 3 10 3 0 0 0
    Rash 3 10 1 2 0 0
    Squamous cell carcinoma 3 10 0 1 2 0
Infections and other
    Herpes simplex 4 14 2 2 0 0
    Urinary tract 4 14 0 4 0 0
    Viral 4 14 4 0 0 0
    Influenza-like illness 3 10 2 1 0 0
    Stomatitis 3 10 1 2 0 0

Abbreviation: RTI, respiratory tract infection.